The Food and Drug Administration is  Chinese-made plastic syringes used to inject or withdraw fluids from the body, citing concern that they may not provide adequate quality and performance, including their ability to deliver the correct dose of medication when used alone or with other medical devices, such as infusion pumps. Meanwhile, health care facilities should use other plastic syringes or closely monitor their use, the agency said. The concern does not currently apply to glass syringes, pre-filled syringes, or syringes used for oral or topical purposes, FDA said.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Feb. 14 announced it ceased implementation of the Hospice Special Focus Program so the agency can further…
Headline
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China. The tariffs for Mexico and Canada have since been delayed…
Headline
The latest revisions to the Centers for Medicare & Medicaid Services’ Quality Assurance and Performance Improvement program underscore the integral role of…
Headline
Draeger Medical, Inc. is recalling its Carina Ventilators due to the presence of contaminants in the device’s airpath, which exceed acceptable levels if…
Headline
Crews are working to restore power and assess damage to a Pfizer plant in North Carolina that makes sterile injectables for U.S. hospitals after a tornado…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…